Home | About | Journals | Submit | Contact Us | Français |

**|**BMJ**|**v.316(7142); 1998 May 9**|**PMC1113123

Formats

Article sections

Authors

Related links

BMJ. 1998 May 9; 316(7142): 1455–1460.

PMCID: PMC1113123

Correspondence to: Mrs Kerry

Copyright © 1998, British Medical Journal

This article has been cited by other articles in PMC.

We have described the calculation of sample size when subjects are randomised in groups or clusters in terms of two variances—the variance of observations taken from individuals in the same cluster, *s _{w}*

This sum of two components of variance is analogous to what happens with measurement error, where we have the variance within the subject, also denoted by *s _{w}*

For cholesterol concentration in the Medical Research Council thrombosis prevention trial the two components of variance were *s _{w}*

The design effect is the ratio of the total number of subjects required using cluster randomisation to the number required using individual randomisation.^{1} It can be presented neatly in terms of the intracluster correlation and the number in a single cluster, *m*: *D*=1+(m−1)*r _{I}*. If there is only one observation per cluster,

The main difficulty in calculating sample size for cluster randomised studies is obtaining an estimate of the between cluster variation or intracluster correlation. Estimates of variation between individuals can often be obtained from the literature but even studies that use the cluster as the unit of analysis may not publish their results in such a way that the between practice variation can be estimated. Recognising this problem, Donner recommended that authors should publish the cluster specific event rates observed in their trial. This would enable other workers to use this information to plan further studies.

*ABC of allergies *In the article on food allergy by Carsten Bindslev-Jensen (25 April, pp 1299-302) we should have credited the illustration of common products containing preservatives to the artist, Lesley Champkins.

*Hypertension treatment and control in sub-Saharan Africa: the epidemiological basis for policy *In this article by Richard S Cooper et al (21 February, pp 614-7), the graphs accompanying the captions for figures 1 and 2 were reversed.

*Cervical screening laboratories should be accredited *Clinical Pathological Accreditation (UK) points out that Health Services Accreditation is not the only organisation to publish results on the internet (News, 21 February, p 572). It has been publishing a list of fully accredited laboratories on the internet since September 1997 (www.cpa-uk.co.uk).

In some trials, where the intervention is directed at the individual subjects and the number of subjects per cluster is small, we may judge that the design effect can be ignored. On the other hand, where the number of subjects per cluster is large, an estimate of the variability between clusters will be important.

1. Kerry SM, Bland JM. Sample size in cluster randomisation. BMJ. 1998;316:549. [PMC free article] [PubMed]

2. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ. 1996;313:41–42. [PMC free article] [PubMed]

3. Meade TW, Roderick PJ, Brennan PJ, Wilkes HC, Kelleher CC. Extracranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation. Thromb Haemostasis. 1992;68:1–6. [PubMed]

4. Oakeshott P, Kerry SM, Williams JE. Randomised controlled trial of the effect of the Royal College of Radiologists’ guidelines on general practitioners’ referral for radiographic examination. Br J Gen Pract. 1994;44:197–200. [PMC free article] [PubMed]

5. Kerry SM, Bland JM. Analysis of a trial randomised in clusters. BMJ. 1998;316:54. [PMC free article] [PubMed]

6. Donner A, Brown KS, Brasher P. A methodological review of non-therapeutic intervention trials employing cluster randomisation 1979-1989. Int J Epidemiol. 1990;19:795–800. [PubMed]

Articles from The BMJ are provided here courtesy of **BMJ Group**

PubMed Central Canada is a service of the Canadian Institutes of Health Research (CIHR) working in partnership with the National Research Council's national science library in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine(NCBI/NLM). It includes content provided to the PubMed Central International archive by participating publishers. |